Company Filing History:
1 out of 1,746 
1 out of 1,863 
Years Active: 2021
Title: Toshie Sakuma: Innovator in Viral Vector Research
Introduction
Toshie Sakuma is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of viral vector research, particularly in methods and materials that enhance viral vector infectivity. His work is crucial for advancements in gene therapy and related biomedical applications.
Latest Patents
Toshie Sakuma holds a patent titled "Methods and materials for increasing viral vector infectivity." This patent focuses on innovative techniques that utilize spliceosome inhibitors, such as U2 snRNP spliceosome inhibitors like meayamycin B or pladienolide derivative E7107, to improve the infectivity of viral vectors, specifically adeno-associated virus-based vectors. He has 1 patent to his name.
Career Highlights
Throughout his career, Sakuma has been associated with prestigious institutions, including the Mayo Foundation for Medical Education and Research and the University of Pittsburgh. His work in these organizations has allowed him to explore and develop groundbreaking methodologies in the field of virology.
Collaborations
Toshie Sakuma has collaborated with several esteemed colleagues, including Yasuhiro Ikeda and Claire A. Schreiber. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Toshie Sakuma's contributions to viral vector research exemplify the importance of innovation in the biomedical field. His patented methods are paving the way for future advancements in gene therapy and related areas.